LOADING
Tag: data
New Data Show Early and Consistent Response to VTAMA® (tapinarof) Cream, 1%, in Children Aged 2+ with Atopic Dermatitis, Including Those With Associated Comorbidities – The Globe and Mail
November 8, 2025
New Data Show Early and Consistent Response to VTAMA® (tapinarof) Cream, 1%, in Children Aged 2+ with Atopic Dermatitis, Including Those With Associated Comorbidities The Globe and Mail Source link
chat_bubble0 Comment
visibility54 Views
LEO Pharma Presents Late-Breaking Phase 3 Delgocitinib Cream Data in Adolescents with Moderate to Severe Chronic Hand Eczema (CHE) – BioSpace
September 19, 2025
LEO Pharma Presents Late-Breaking Phase 3 Delgocitinib Cream Data in Adolescents with Moderate to Severe Chronic Hand Eczema (CHE) BioSpace Source link
chat_bubble0 Comment
visibility80 Views
SLIDESHOW: Recent Data from LEO Pharma on Chronic Hand Eczema – Dermatology Times
June 17, 2025
SLIDESHOW: Recent Data from LEO Pharma on Chronic Hand Eczema Dermatology Times Source link
chat_bubble0 Comment
visibility99 Views
New Analysis of Organon’s VTAMA® (tapinarof) cream, 1% Phase 3 Data Shows Atopic Dermatitis Disease Activity Remained Low After Treatment-Free Interval in Adults and Children 2 Years of Age and Older – Business Wire
March 9, 2025
New Analysis of Organon’s VTAMA® (tapinarof) cream, 1% Phase 3 Data Shows Atopic Dermatitis Disease Activity Remained Low After Treatment-Free Interval in Adults and Children 2 Years of Age and Older Business Wire Source link
chat_bubble0 Comment
visibility150 Views